Trupanion Inc (TRUP) Stock AnalysisTRUPTrupanion Inc

Trupanion, Inc. is a medical insurance provider for cats and dogs throughout the United States, Canada, and certain countries in Continental Europe. The Company operates in two segments, namely, Subscription Business and Other Business. The Subscription Business segment is based on subscription payments related to the Company’s direct-to-consumer products. The Other business segment is focuses on other product offerings, primarily involving the underwriting of policies on behalf of third parties with whom the Company maintains business-to-business relationships. It offers Trupanion, software that is designed to communicate directly with veterinary hospital's practice management software. It provides Powered by Trupanion pet insurance product offerings marketed by third parties and marketed under the brand names Furkin and PHI Direct in Canada, and a Trupanion branded product in Germany and Switzerland. It operates in the Financials sector (HOSPITAL & MEDICAL SERVICE PLANS industry).

Trupanion Inc is currently priced at $29.32, which is near the analyst price target range of $30 to $32. The stock has shown a 5-day increase of 4.27% and a significant year-over-year revenue growth of 11% in Q2 2026, indicating potential for recovery. However, the RSI is at 71.298, suggesting the stock may be overbought, and the forward P/E ratio is extremely high at 1428.57, indicating potential overvaluation. The main risk is the declining trend in the pet insurance market, as highlighted by Piper Sandler's downgrade due to a contraction in U.S. puppy vet visits, which could impact future growth.

6 analysts cover TRUP: 6 rate it Buy, 0 Hold and 0 Sell. The average price target is 54.40.